Abstract
Class-action lawsuits against the company that manufactures the type 2 diabetes drug rosiglitazone (Avandia®) also name the federal government, accusing Health Canada of failing to protect the public from the medication’s “serious adverse medical events.” The lawsuits, which the Merchant Law
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
